Conversely, a recent study investigating the development of subclinical atherosclerosis in adult patients with severe OSA found that plasma FOXP3 expression and FOXP3 intron 1 methylation was no different than that of control patients regardless of C-reactive protein expression [64]. The gene discussed is FOXP3; the disease is atherosclerosis.